AMERICAN CRYOSTEM Corp (CRYO) Financial Statements (2024 and earlier)
Company Profile
Business Address |
1 MERIDIAN ROAD EATONTOWN, NJ 07724 |
State of Incorp. | NV |
Fiscal Year End | September 30 |
Industry (SIC) | 809 - Miscellaneous Health And Allied Services, Not (benchmarking) |
More info | Complete Financial Analysis Financial Benchmarking |
Balance Sheet (Statement of Financial Position) ($ in thousands)Annual | Quarterly
6/30/2022 Q3 | 3/31/2022 Q2 | 12/31/2021 Q1 | 9/30/2021 Q4 | 6/30/2021 Q3 | 3/31/2021 Q2 | 12/31/2020 Q1 | |||
---|---|---|---|---|---|---|---|---|---|
ASSETS | |||||||||
Current Assets | |||||||||
Cash, cash equivalents, and short-term investments | 23 | 103 | 8 | 7 | 109 | 31 | |||
Cash and cash equivalents | 23 | 103 | 8 | 7 | 109 | 31 | |||
Receivables | 66 | 84 | 79 | 875 | 754 | 627 | |||
Inventory, net of allowances, customer advances and progress billings | 19 | 24 | 18 | 26 | 22 | 22 | |||
Inventory | 19 | 24 | 18 | 26 | 22 | 22 | |||
Prepaid expense | 44 | 38 | 53 | 47 | 13 | ||||
Other undisclosed current assets | 39 | 39 | 39 | ||||||
Total current assets: | 191 | 288 | 197 | 908 | 932 | 692 | |||
Noncurrent Assets | |||||||||
Finance lease, right-of-use asset, after accumulated amortization | 100 | 108 | 116 | 77 | 81 | ||||
Operating lease, right-of-use asset | 61 | 3 | 10 | ||||||
Property, plant and equipment | 107 | 110 | 113 | 189 | 120 | 123 | |||
Intangible assets, net (including goodwill) | 414 | 378 | 372 | 368 | 355 | 373 | |||
Intangible assets, net (excluding goodwill) | 414 | 378 | 372 | 368 | 355 | 373 | |||
Other undisclosed noncurrent assets | 258 | 258 | 258 | 314 | 314 | 314 | |||
Total noncurrent assets: | 941 | 854 | 859 | 870 | 868 | 901 | |||
TOTAL ASSETS: | 1,132 | 1,142 | 1,056 | 1,778 | 1,800 | 1,594 | |||
LIABILITIES AND EQUITY | |||||||||
Liabilities | |||||||||
Current Liabilities | |||||||||
Accounts payable and accrued liabilities, including: | 436 | 244 | 553 | 310 | 287 | 191 | |||
Other undisclosed accounts payable and accrued liabilities | 436 | 244 | 553 | 310 | 287 | 191 | |||
Debt | 765 | 766 | 631 | 597 | 603 | 598 | |||
Estimated litigation liability | 110 | 46 | 98 | 61 | 29 | 20 | |||
Other liabilities | 227 | 227 | 227 | 227 | 227 | 227 | |||
Other undisclosed current liabilities | 80 | 84 | 122 | 3 | 10 | ||||
Total current liabilities: | 1,617 | 1,367 | 1,631 | 1,194 | 1,147 | 1,045 | |||
Noncurrent Liabilities | |||||||||
Long-term debt and lease obligation | 33 | 3 | 144 | 129 | 127 | 9 | |||
Long-term debt, excluding current maturities | 133 | 129 | 127 | 9 | |||||
Finance lease, liability | 3 | 12 | |||||||
Liabilities, other than long-term debt | 132 | 130 | 1 | 1 | 148 | 99 | |||
Due to related parties | 132 | 130 | 1 | 1 | 148 | 99 | |||
Operating lease, liability | 33 | ||||||||
Other undisclosed noncurrent liabilities | 1,144 | 1,073 | 1,128 | 1,068 | 860 | 800 | |||
Total noncurrent liabilities: | 1,309 | 1,207 | 1,273 | 1,198 | 1,135 | 908 | |||
Total liabilities: | 2,925 | 2,574 | 2,904 | 2,392 | 2,283 | 1,953 | |||
Equity | |||||||||
Equity, attributable to parent | (1,794) | (1,431) | (1,848) | (614) | (482) | (360) | |||
Preferred stock | 0 | 0 | |||||||
Common stock | 44 | 44 | 61 | 61 | 60 | 60 | |||
Additional paid in capital | 18,785 | 18,184 | 17,369 | 16,541 | 16,206 | 16,024 | |||
Accumulated deficit | (20,622) | (19,659) | (19,278) | (17,215) | (16,749) | (16,444) | |||
Total equity: | (1,794) | (1,431) | (1,848) | (614) | (482) | (360) | |||
TOTAL LIABILITIES AND EQUITY: | 1,132 | 1,142 | 1,056 | 1,778 | 1,800 | 1,594 |
Income Statement (P&L) ($ in thousands)Annual | Quarterly
6/30/2022 Q3 | 3/31/2022 Q2 | 12/31/2021 Q1 | 9/30/2021 Q4 | 6/30/2021 Q3 | 3/31/2021 Q2 | 12/31/2020 Q1 | ||
---|---|---|---|---|---|---|---|---|
Revenues | 32 | 61 | (363) | 130 | 127 | 127 | ||
Cost of revenue | (3) | (19) | (5) | (1) | (5) | (3) | ||
Gross profit: | 29 | 42 | (368) | 129 | 122 | 123 | ||
Operating expenses | (967) | (397) | (1,615) | (571) | (397) | (172) | ||
Operating loss: | (938) | (354) | (1,982) | (442) | (275) | (49) | ||
Nonoperating income (Debt Instrument, Convertible, Beneficial Conversion Feature) | 25 | |||||||
Interest and debt expense | (22) | (23) | (22) | (21) | (22) | (16) | ||
Loss from continuing operations before equity method investments, income taxes: | (960) | (377) | (1,979) | (463) | (297) | (65) | ||
Other undisclosed loss from continuing operations before income taxes | (19) | |||||||
Loss from continuing operations: | (960) | (377) | (1,998) | (463) | (297) | (65) | ||
Loss before gain (loss) on sale of properties: | (960) | (377) | (1,998) | (463) | (297) | (65) | ||
Other undisclosed net income (loss) | (8) | 19 | ||||||
Net loss: | (960) | (377) | (1,998) | (463) | (305) | (46) | ||
Other undisclosed net loss attributable to parent | (3) | (3) | (65) | (3) | ||||
Net loss available to common stockholders, diluted: | (964) | (381) | (2,062) | (466) | (305) | (46) |
Comprehensive Income ($ in thousands)Annual | Quarterly
6/30/2022 Q3 | 3/31/2022 Q2 | 12/31/2021 Q1 | 9/30/2021 Q4 | 6/30/2021 Q3 | 3/31/2021 Q2 | 12/31/2020 Q1 | ||
---|---|---|---|---|---|---|---|---|
Net loss: | (960) | (377) | (1,998) | (463) | (305) | (46) | ||
Comprehensive loss, net of tax, attributable to parent: | (960) | (377) | (1,998) | (463) | (305) | (46) |
Statements Sources
The financial statements are based on the Company's filings with the U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.